Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010–2011
Author(s) -
Fiona P. Havers,
Leslie Z. Sokolow,
David K. Shay,
Monica M. Farley,
Maya Monroe,
James Meek,
Pam Daily Kirley,
Nancy M. Bennett,
Craig Morin,
Deborah Aragon,
Ann Thomas,
William Schaffner,
Shelley M. Zansky,
Jan Baumbach,
Jill M. Ferdinands,
Alicia M. Fry
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw512
Subject(s) - medicine , influenza vaccine , covid-19 , medline , virology , intensive care medicine , emergency medicine , pediatrics , vaccination , infectious disease (medical specialty) , disease , outbreak , political science , law
Older adults are at increased risk of influenza-associated complications, including hospitalization, but influenza vaccine effectiveness (VE) data are limited for this population. We conducted a case-control study to estimate VE to prevent laboratory-confirmed influenza hospitalizations among adults aged ≥50 years in 11 US Emerging Infections Program hospitalization surveillance sites.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom